nicardipine has been researched along with ovalbumin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleixandre, MA; Ayala, LE; García Mora, L | 1 |
| Fujimura, M; Ishizaki, T; Kanamori, K; Koshino, T; Matsuda, T; Minami, S; Miyabo, S; Nishioka, S; Okafuji, K; Saga, T | 1 |
| Cabral, MD; Druet, P; Gallard, A; Gomes, B; Guéry, JC; Leclerc, C; Mariamé, B; Moreau, M; Paulet, P; Pelletier, L; Savignac, M | 1 |
3 other study(ies) available for nicardipine and ovalbumin
| Article | Year |
|---|---|
Evaluation of different drugs in two models of immediate hypersensitivity.
Topics: Animals; Cromolyn Sodium; Diethylcarbamazine; Diltiazem; Female; Guinea Pigs; Histamine H1 Antagonists; Hypersensitivity, Immediate; In Vitro Techniques; Isometric Contraction; Male; Nicardipine; Ovalbumin; Passive Cutaneous Anaphylaxis; Quinazolines; Trachea; Verapamil | 1988 |
Effects of Ca2+ antagonist, nicardipine, on experimental asthma with special reference to slow reacting substance of anaphylaxis.
Topics: Airway Resistance; Animals; Antigens; Asthma; Calcium Channel Blockers; Guinea Pigs; Male; Nicardipine; Nifedipine; Ovalbumin; SRS-A | 1985 |
Calcium channel blocker prevents T helper type 2 cell-mediated airway inflammation.
Topics: Administration, Intranasal; Animals; Asthma; Bronchoalveolar Lavage Fluid; Calcium; Calcium Channel Blockers; CD4-Positive T-Lymphocytes; Cell Proliferation; Dendritic Cells; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Inflammation; Injections, Intraperitoneal; Intracellular Fluid; Lung; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Transgenic; Nicardipine; Ovalbumin; Severity of Illness Index; Th2 Cells | 2007 |